We have located links that may give you full text access.
Pilot imaging of the colony stimulating factor 1 receptor in the brains of virally-suppressed individuals with HIV.
AIDS 2023 April 7
OBJECTIVE: Neuroimmune activation is a putative driver of cognitive impairment in people with HIV (PWH), even in the age of modern antiretroviral therapy. Nevertheless, imaging of the microglial marker, the 18kDa translocator protein (TSPO), with positron emission tomography (PET) in treated PWH has yielded inconclusive findings. One potential reason for the varied TSPO results is a lack of cell-type specificity of the TSPO target.
DESIGN: [11C]CPPC is a radiotracer for use with PET to image the colony stimulating factor 1 receptor (CSF1R). The CSF1R is expressed on microglia and central nervous system macrophages, with little expression on other cell types. We used [11C]CPPC PET in virally-suppressed- (VS)-PWH and HIV-uninfected individuals to estimate the effect sizes of higher CSF1R in the brains of VS-PWH.
METHODS: Sixteen VS-PWH and 15 HIV-uninfected individuals completed [11C]CPPC PET. [11C]CPPC binding (VT) in nine regions was estimated using a one-tissue compartmental model with a metabolite-corrected arterial input function, and compared between groups.
RESULTS: Regional [11C]CPPC VT did not significantly differ between groups after age- and sex- adjustment (unstandardized beta coefficient [B] = 1.84, standard error [SE] = 1.18, P = 0.13). The effect size was moderate (Cohen's d = 0.56, 95%confidence interval [CI] -0.16, 1.28), with strongest trend of higher VT in VS-PWH in striatum and parietal cortex (each P = 0.04; Cohen's d = 0.71 and 0.72 respectively).
CONCLUSIONS: Group difference in [11C]CPPC VT was not observed between VS-PWH and HIV-uninfected individuals in this pilot, although the observed effect sizes suggest the study was underpowered to detect regional group differences in binding.
DESIGN: [11C]CPPC is a radiotracer for use with PET to image the colony stimulating factor 1 receptor (CSF1R). The CSF1R is expressed on microglia and central nervous system macrophages, with little expression on other cell types. We used [11C]CPPC PET in virally-suppressed- (VS)-PWH and HIV-uninfected individuals to estimate the effect sizes of higher CSF1R in the brains of VS-PWH.
METHODS: Sixteen VS-PWH and 15 HIV-uninfected individuals completed [11C]CPPC PET. [11C]CPPC binding (VT) in nine regions was estimated using a one-tissue compartmental model with a metabolite-corrected arterial input function, and compared between groups.
RESULTS: Regional [11C]CPPC VT did not significantly differ between groups after age- and sex- adjustment (unstandardized beta coefficient [B] = 1.84, standard error [SE] = 1.18, P = 0.13). The effect size was moderate (Cohen's d = 0.56, 95%confidence interval [CI] -0.16, 1.28), with strongest trend of higher VT in VS-PWH in striatum and parietal cortex (each P = 0.04; Cohen's d = 0.71 and 0.72 respectively).
CONCLUSIONS: Group difference in [11C]CPPC VT was not observed between VS-PWH and HIV-uninfected individuals in this pilot, although the observed effect sizes suggest the study was underpowered to detect regional group differences in binding.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app